Guido Galley

980 total citations
22 papers, 767 citations indexed

About

Guido Galley is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Guido Galley has authored 22 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Guido Galley's work include Receptor Mechanisms and Signaling (7 papers), Asymmetric Synthesis and Catalysis (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Guido Galley is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Asymmetric Synthesis and Catalysis (6 papers) and Neuroscience and Neuropharmacology Research (5 papers). Guido Galley collaborates with scholars based in Switzerland, Germany and United States. Guido Galley's co-authors include Michael Pätzel, Roger D. Norcross, Marius C. Hoener, Peter G. Jones, Amyaouch Bradaïa, Joseph G. Wettstein, Katrin Groebke Zbinden, Andreas Bruns, J‐L Moreau and Céline Risterucci and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Guido Galley

22 papers receiving 726 citations

Peers

Guido Galley
Victor I. Ilyin United States
Raymond G. Booth United States
Kevin J. Merchant United States
Eric Vieira Switzerland
Virginia L. Lucaites United States
Cor J. Grol Netherlands
Josephine A. Stanton United Kingdom
Victor I. Ilyin United States
Guido Galley
Citations per year, relative to Guido Galley Guido Galley (= 1×) peers Victor I. Ilyin

Countries citing papers authored by Guido Galley

Since Specialization
Citations

This map shows the geographic impact of Guido Galley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Galley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Galley more than expected).

Fields of papers citing papers by Guido Galley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Galley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Galley. The network helps show where Guido Galley may publish in the future.

Co-authorship network of co-authors of Guido Galley

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Galley. A scholar is included among the top collaborators of Guido Galley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Galley. Guido Galley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Härtung, Thomas, René Trussardi, Hans Iding, et al.. (2016). Synthesis of enantiomerically pure [14C]‐labelled morpholine derivatives for a class of trace amine‐associate receptor 1 agonists. Journal of Labelled Compounds and Radiopharmaceuticals. 59(14). 635–639. 5 indexed citations
2.
Galley, Guido, Susanne Mohr, Axel Pähler, et al.. (2015). Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 Agonists. ACS Medicinal Chemistry Letters. 7(2). 192–197. 42 indexed citations
3.
Revel, Florent G., Claas A. Meyer, Amyaouch Bradaïa, et al.. (2012). Brain-Specific Overexpression of Trace Amine-Associated Receptor 1 Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine. Neuropsychopharmacology. 37(12). 2580–2592. 84 indexed citations
4.
Moreau, J‐L, Bruno Pouzet, Roland Mory, et al.. (2012). A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight. Molecular Psychiatry. 18(5). 543–556. 211 indexed citations
5.
Galley, Guido, et al.. (2012). Optimisation of imidazole compounds as selective TAAR1 agonists: Discovery of RO5073012. Bioorganic & Medicinal Chemistry Letters. 22(16). 5244–5248. 46 indexed citations
6.
Galley, Guido, et al.. (2012). ChemInform Abstract: Optimization of Imidazole Compounds as Selective TAAR1 Agonists: Discovery of RO5073012.. ChemInform. 43(48). 2 indexed citations
7.
Mayweg, A., Urs Hofer, Patrick Schnider, et al.. (2011). ROCK: the Roche medicinal chemistry knowledge application – design, use and impact. Drug Discovery Today. 16(15-16). 691–696. 15 indexed citations
8.
Fukumori, Akio, Richard Page, Thomas Luebbers, et al.. (2011). Attenuated Aβ42 Responses to Low Potency γ-Secretase Modulators Can Be Overcome for Many Pathogenic Presenilin Mutants by Second-generation Compounds. Journal of Biological Chemistry. 286(17). 15240–15251. 40 indexed citations
9.
Peters, Jens‐Uwe, Guido Galley, Helmut Jacobsen, et al.. (2007). Novel orally active, dibenzazepinone-based γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(21). 5918–5923. 31 indexed citations
10.
Kitas, Eric, Guido Galley, Roland Jakob‐Roetne, et al.. (2007). Substituted 2-oxo-azepane derivatives are potent, orally active γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(1). 304–308. 17 indexed citations
11.
Hoffmann, Torsten, Michael Bös, Heinz Stadler, et al.. (2005). Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(5). 1362–1365. 34 indexed citations
12.
Roever, S., Geo Adam, Andrea M. Cesura, et al.. (2000). ChemInform Abstract: High‐Affinity, Nonpeptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor.. ChemInform. 31(28). 9 indexed citations
13.
Röver, Stephan, Geo Adam, Andrea M. Cesura, et al.. (2000). High-Affinity, Non-Peptide Agonists for the ORL1 (Orphanin FQ/Nociceptin) Receptor. Journal of Medicinal Chemistry. 43(7). 1329–1338. 68 indexed citations
14.
Grubert, Lutz, Guido Galley, & Michael Pätzel. (1996). Diastereoselective 1,3-dipolar cycloaddition of nitrilimines to γ-oxygenated α,β-unsaturated enones and esters. Tetrahedron Asymmetry. 7(4). 1137–1148. 11 indexed citations
15.
Galley, Guido, et al.. (1996). Diastereoselective conjugate addition and cyclopropanation reactions with nitroalkenes derived from (R)-2,3-isopropylidene glyceraldehyde. Tetrahedron Letters. 37(35). 6307–6310. 22 indexed citations
16.
Galley, Guido & Michael Pätzel. (1996). Chiral dienes from enantiomerically pure enones. Highly stereoselective intramolecular Diels–Alder reaction involving ethenesulfonates. Journal of the Chemical Society Perkin Transactions 1. 2297–2302. 8 indexed citations
17.
Galley, Guido, Peter G. Jones, & Michael Pätzel. (1996). Enantiomerically pure isoxazolines by stereoselective 1,3-dipolar cycloaddition of silyl nitronates. Tetrahedron Asymmetry. 7(7). 2073–2082. 20 indexed citations
18.
Galley, Guido, Michael Pätzel, & Peter G. Jones. (1995). Diastereofacial selectivity of the cycloaddition of diazo compounds to enones. Tetrahedron. 51(6). 1631–1640. 20 indexed citations
19.
Galley, Guido, et al.. (1995). Polyfunctionalized Pyrrolidines by Stereoselective 1,3-Dipolar Cycloaddition of Azomethine Ylides to Chiral Enones. The Journal of Organic Chemistry. 60(16). 5005–5010. 47 indexed citations
20.
Galley, Guido, Clemens Mügge, Peter G. Jones, & Michael Pätzel. (1995). Diastereofacial selectivity in the Diels-Alder reaction of 5(S)-E-5,6-O-isopropyliden-hex-3-en-2-one with cyclopentadiene. Tetrahedron Asymmetry. 6(9). 2313–2318. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026